The aim of this review is to summarize the data on the efficacy and safety of inhaled anticholinergic drugs in asthma, and to propose a possible use of these drugs in asthma management.
(NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces partial final results showcasing the tolerability and glycemic control efficacy ...